Internationale Partnersuche

Innovation & Technologie Angebot

Innovative solutions for human autologous fat grafting for plastic and reconstructive surgery

Country of Origin: France
Reference Number: TOFR20180219002
Publication Date: 21 February 2018

Summary

An innovative French SME acting in the biotechnology field has developed new solutions for human autologous fat grafting, bringing real benefits to patients and practitioners. There is a substantial improvement in the survival of the grafted fat. The company is seeking for commercial agreements with technical assistance, with companies in the plastic and reconstructive surgery fields.

Description

The innovative company working in the field of plastic and reconstructive surgery was funded by two researchers, specialists in human adipose tissue and internationally recognised for their work in this field. 



Derived from the latest cellular engineering techniques, their products contribute to the satisfaction and the comfort of the surgeon and the patient. The company offers a wide range of lipofilling kits, all adapted for specific needs (breast augmentation, body modelling, facial rejuvenation, scars treatments,...).



The company has developed each kit focusing on the critical points of the Coleman technique conventionally used by surgeons to improve the survival of the grafted fat (usually reaching 40 to 50 %). The critical points of the lipofilling technique are respected with this innovative protocol : infiltration, sampling with adapted cannulas and controlled vacuum, centrifugation and washing of the tissue in closed circuit and injection with adapted cannulas.



All these points have been carefully studied leading to scientific publications.



With this technique, tissue survival will drastically improve up to 70 - 90 %.



Even though, the company's network of partnerships is constantly growing and they are represented in Europe, Asia and in Australasia, the company is looking for new commercial agreements with technical assistance to expand this network and reach more countries.

Advantages and Innovations

In house R&D team

Products certification

Sterile and single use kits

2 patents (+ a new one in preparation)

Several years of research

Stage Of Development

Already on the market

Stage Of Development Comment

CE mark, TGA (therapeutic goods administration - Australia) approved

Requested partner

The French company is seeking companies that can distribute the product in Europe (France, Switzerland, Germany, Norway, Finland, Denmark), Middle East (Iran, Israël, Saudi Arabia, Egypt, Kuwait, Lebanon, Morocco, Tunisia), Asia (Singapore, Vietnam, India), Canada and Latin America or  restricted countries that can help to reach these geographical areas (see restrict dissemination to specific countries).



The sales representatives should have their distribution channel in plastic and reconstructive surgery and be able to go to operating room and assist surgeons during their first operations with products. 



Target companies/agents are those already active in distribution of surgical instruments and/or distributors of breast implants. 



The French company will provide technical assistance through training and assistance to distributors/agents in their first sales.

Dissemination Countries

Argentina, Brazil, Switzerland, Chile, Germany, Denmark, Egypt, Finland, France, Israel, Norway, Peru, Paraguay, Singapore, Tunisia, Vietnam